Ask Orbit
Sales Performance
Commercial Performance/Secondary Sales

Secondary Sales

End-channel demand across customers, products, regions and territories.

1 – 30 Jun 2026·All Divisions·All Regions·All Categories·Value view
Demo Data
View
Customer
Status
Scope
Orbit Secondary-Sales Briefing
Updated 14 min ago

Secondary sales grew by +2.8%, but remain below target. Western Cape and KZN are performing strongly, while Gauteng North accounts for 46% of the national gap. Customer Y has declined for three consecutive months, and two high-demand products show reduced sales where stock cover is low.

Net Secondary Sales
R281.5m
+2.8% vs prev period
Units Sold
9.2m
+2.1% vs prev period
Secondary Growth
+2.8%
Slowing
Slower than primary
Target Attainment
89.6%
Below
R32.7m gap to plan
Active Customers
4,286
+3.4% vs prev period
Avg Sales / Customer
R65.7k
-0.6% vs prev period
Secondary Sales Trend
Actual, target, prior year & forecast
Actual
Target
Prev year
Forecast
Geographic performance
Secondary sales by region
Gauteng
R96.4m-2.4%84%
Western Cape
R58.1m+11.2%108%
KwaZulu-Natal
R47.9m+6.8%102%
Eastern Cape
R26.7m-1.1%89%
Free State
R18.2m+4.2%98%
Northern Cape
R8.9m+1.8%93%
Mpumalanga
R15.4m+3.2%95%
Limpopo
R9.9m-0.8%88%
Top growing customers
Highest MoM growth
Top declining customers
Steepest MoM decline
Customer lifecycle
Customer counts this period
New312
Retained3184
Declining486
Lapsed304
Customer value vs frequency
Identify loyal, lapse-risk and underdeveloped customers
Risks & opportunities
Prioritised for this period
Risks
Gauteng North below target-16 pp
Customer Y declining for 3 months-19%
High-value customers with no purchase8 accts
Demand constrained by low stock coverR1.4m
Opportunities
WC growth with low product penetration+R1.2m
New customers with rapid growth312 new
Underdeveloped single-product customers+R0.9m
High demand in under-distributed territories+R0.7m
Secondary sales detail
By customer, product and representative · click a row to open the customer
DateCustomerTypeRegionTerritoryRepProductUnitsNetTargetGrowthStatusStock
2026-06-28MediRite SandtonRetail PharmacyGautengSandton NorthL. NaidooCardiaxol 20mg640R0.14mR0.12m+18.2%Retained
2026-06-28Netcare PinelandsHospitalWestern CapeCape MetroT. AdamsRespireze Inhaler210R0.09mR0.07m+22.1%Growing
2026-06-27Key Account YChain PharmacyWestern CapeCape MetroT. AdamsNeurospen 50090R0.03mR0.06m-19.4%Declining
2026-06-27Life Hospital UmhlangaHospitalKwaZulu-NatalDurban NorthS. PillayGastraven 20mg320R0.11mR0.09m+16.4%Growing
2026-06-26Dis-Chem MenlynChain PharmacyGautengPretoria EastR. van WykCardiaxol 40mg440R0.12mR0.14m-6.1%Retained
2026-06-26Clicks RondeboschChain PharmacyWestern CapeCape MetroT. AdamsGastraven Chewable180R0.06mR0.05m+12.8%Retained
2026-06-25Pharmacy Group QIndependentGautengSandton NorthL. NaidooPulmavent DPI60R0.02mR0.05m-22.4%Declining
2026-06-25Metro Clinic GroupClinicEastern CapePE MetroN. DlaminiMetaform 850120R0.03mR0.05m-8.6%Declining
2026-06-24Corner Pharm AIndependentFree StateBloemfonteinP. CoetzeeRespireze Inhaler40R0.02mR0.02m+4.1%Retained
Commercial Performance
Back to the combined view
Primary Sales
Inspect replenishment position
Executive Overview
Executive summary